[Pharmacogenomics: hype or hope?]


Pharmacogenomics follows the concept of individualized medicine via targeted and tailored therapy for each patient. This is aided by current progress in human genome research that provided the basis to link genetic markers with pathogenesis and progression for the definition of new therapy options. To achieve this it will be necessary to show the validity and clinical utility of pharmacogenomic tests prior to release. The implementation of pharmacogenomics into clinical practise is a momentous future challenge that requires the establishment of interdisciplinary networks and professional organizations.


Projects: A3.4: Linking signalling to metabolic functions, B5: Cell-cell communication influences detoxifying functions in hepatocytes, G2: Clinical Translation to Non-Invasive Volunteer Setting

Dtsch. Med. Wochenschr.
Dtsch. Med. Wochenschr. 136(10): 461-7
1st Mar 2011

M Schwab, E Schaeffeler, U M Zanger, H Brauch, H K Kroemer

help Authors

[Matthias Schwab] [Ulrich Zanger]

help Attributions


help Scales

Views: 2245
  • Created: 27th Jun 2012 at 16:14
  • Last updated: 24th Oct 2013 at 16:19

Related items


Log in / Register

Need an account?
Sign up

Forgotten password?

Front Page

Virtual Liver Network


Related Projects and friends

Imprint Taverna workflow workbench myExperiment JWS Online ISATAB myGrid Sabio-RK BioPortal Semantic SBML

Powered by:


Silk icons 1.3
Crystal Clear icons

Virtual Liver Seek uses one essential cookie to keep you session open and one cookie to keep your consent.

By continuing to use this site you agree to the use of cookies